Video

Treatments and Symptoms of Asthma in Children

Symptoms include airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.

Asthma is a chronic disease of the airways that is complex with variable and reoccurring symptoms. Symptoms include airflow obstruction (bronchial constriction and mucus) bronchial hyperresponsiveness, and airway inflammation.

Related Videos
Image Credit: © Birdland - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
Image Credit: © Andrey Popov - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Pharmacists working in a pharmacy -- Image credit: Drazen | stock.adobe.com
Related Content
Oral Semaglutide, GLP-1, Diabetes, MACE | Image Credit: Chinnapong - stock.adobe.com
October 29th 2024

Oral Semaglutide Reduces Risk of MACE for Patients With Type 2 Diabetes

Ashley Gallagher, Associate Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Pharmacy, Biosimilar, Humira, Stelara | Image Credit: Jacob Lund -stock.adobe.com
October 28th 2024

The Future of Biosimilars: Learning from Prior Mistakes

Mark Campbell, PharmD
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

FDA, Semaglutide, Ozempic, Novo Nordisk | Image Credit: Araki Illustrations - stock.adobe.com
October 25th 2024

Novo Nordisk Calls for FDA to Prohibit Compounding Pharmacies from Providing Semaglutide

Ashley Gallagher, Associate Editor
Gene therapy -- Image credit: RFBSIP | stock.adobe.com
Published: October 25th 2024 | Updated: October 25th 2024

FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a

Gillian McGovern, Assistant Editor